Delcath Systems, Inc. (NASDAQ: DCTH) is a specialty pharmaceutical and medical device company focused on oncology with an emphasis on the treatment of primary and metastatic liver cancers, according to the company’s website (see here: www.Delcath.com). In this SNNLive On-Location, our host spoke with Dr. Jennifer K. Simpson, Ph.D., MSN, CRNP, President and CEO of Delcath Systems, Inc. in New York City, NY.
In this video interview, Dr. Simpson and our host discuss the following topics:
- Overview of Delcath Systems, Inc.
- Describes Delcath’s technology
- Comments on the phrase, “targeted”
- Discusses clinical development
- Dr. Simpson’s background and experience
Since speaking with Dr. Simpson, the company has made the following announcements:
For more information about Delcath Systems, Inc., go to: www.Delcath.com
© 2017 Stock News Now
Supported by Superior Web Solutions